Table 5.
Characteristic | Univariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|---|
HR | P Value | HR | P Value | 95% CI | |
Age | |||||
< 50 y | Referent | Referent | |||
≥50 y | 0.4 | <0.0001 | 0.6 | 0.01 | 0.4–0.9 |
IM drainage | 1.5 | 0.07 | 1.6 | 0.037 | 1.03–2.6 |
UOQ tumor location | 1.1 | 0.8 | |||
Medial tumor location | 1.3 | 0.2 | 1.5 | 0.2 | 0.9–2.5 |
LVI | 2.7 | <0.0001 | 2.0 | 0.005 | 1.2–3.4 |
Nuclear grade | |||||
1 | Referent | ||||
2 | 1.3 | 0.6 | 1.1 | 0.8 | 0.4–2.7 |
3 | 3.8 | 0.002 | 2.0 | 0.1 | 0.8–5.3 |
Tumor stage | |||||
T1 | Referent | Referent | |||
T2 | 3.4 | <0.0001 | 2.6 | <0.0001 | 1.7–4.1 |
T3 | 8.3 | <0.0001 | 4.5 | 0.001 | 1.9–10.6 |
Negative ER status | 3.4 | <0.0001 | 3.2 | <0.0001 | 2.0–5.0 |
Negative PR status | 1.6 | 0.03 | 0.9 | 0.7 | 0.5–1.5 |
Negative HER-2 status | 1.1 | 0.7 | |||
Tumor histology | |||||
IDC | Referent | ||||
ILC | 1.1 | 0.7 | |||
IDC and ILC | 0.69 | 0.4 | |||
Other | 0.8 | 0.7 | |||
Number of positive LNsa | 1.1 | <0.0001 | 1.6 | 0.006 | 1.1–2.2 |
HR indicates hazards ratio; CI, confidence interval; IM, internal mammary; UOQ, upper outer quadrant; LVI, lymphovascular invasion; ER, estrogen receptor; PR, progesterone receptor; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; LN, lymph node.
As a continuous variable.